These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 37324186)
1. FANCI is Associated with Poor Prognosis and Immune Infiltration in Liver Hepatocellular Carcinoma. Hou Y; Li J; Yu A; Deng K; Chen J; Wang Z; Huang L; Ma S; Dai X Int J Med Sci; 2023; 20(7):918-932. PubMed ID: 37324186 [No Abstract] [Full Text] [Related]
2. Integrative Multi-Omics Analysis of Identified Ferroptosis-Marker RPL8 as a Candidate Oncogene Correlates with Poor Prognosis and Immune Infiltration in Liver Cancer. Fan S; Zhang S; Kong D; Wang H; Shi Y; Wang Z; Zheng H Comb Chem High Throughput Screen; 2023; 26(7):1298-1310. PubMed ID: 36017842 [TBL] [Abstract][Full Text] [Related]
3. DDR1 is a Novel Biomarker and Potential Therapeutic Target for the Combination Treatment of Liver Hepatocellular Carcinoma. Li T; Hu H; Song Y; Shi Y; Hu D; Shen W; Ning B Cancer Control; 2024; 31():10732748241286257. PubMed ID: 39284684 [TBL] [Abstract][Full Text] [Related]
4. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases. Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537 [No Abstract] [Full Text] [Related]
5. PDCL3 is a prognostic biomarker associated with immune infiltration in hepatocellular carcinoma. Jin W; Wang G; Dong M; Wang X Eur J Med Res; 2024 Mar; 29(1):177. PubMed ID: 38494503 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of the correlation of the pan-cancer gene HAUS5 with prognosis and immune infiltration in liver cancer. Zhang W; Yang C; Hu Y; Yi K; Xiao W; Xu X; Chen Z Sci Rep; 2023 Feb; 13(1):2409. PubMed ID: 36765148 [TBL] [Abstract][Full Text] [Related]
7. The Prognostic Significance of Li Z; Cui Y; Duan Q; Zhang J; Shao D; Cao X; Gao Y; Wang S; Li J; Jones OD; Lei X; Wang L; Zhou X; Xu M; Ma J; Liu Y; Xu X Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361587 [TBL] [Abstract][Full Text] [Related]
8. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma. Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688 [TBL] [Abstract][Full Text] [Related]
9. [Bioinformatics analysis of core differentially expressed genes in hepatitis B virus-related hepatocellular carcinoma]. Yu Y; Cheng J; Mei CZ; Dai YZ Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Nov; 34(5):507-513. PubMed ID: 36464255 [TBL] [Abstract][Full Text] [Related]
10. CD93 overexpresses in liver hepatocellular carcinoma and represents a potential immunotherapy target. Jiang Q; Kuai J; Jiang Z; Que W; Wang P; Huang W; Ding W; Zhong L Front Immunol; 2023; 14():1158360. PubMed ID: 37483608 [TBL] [Abstract][Full Text] [Related]
11. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma. Su Q; Li W; Zhang X; Wu R; Zheng K; Zhou T; Dong Y; He Y; Wang D; Ran J Curr Pharm Biotechnol; 2023; 24(8):1035-1058. PubMed ID: 35762549 [TBL] [Abstract][Full Text] [Related]
12. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma. Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157 [TBL] [Abstract][Full Text] [Related]
13. High expression of RNF31 is associated with tumor immune cell infiltration and leads to poor prognosis in liver hepatocellular carcinoma. Xi G; Cheng R; Liang L; Che N; Wang Y; Zhao N; Liang X; Shao B; Zhao X; Zhang D Sci Rep; 2023 Apr; 13(1):6957. PubMed ID: 37117215 [TBL] [Abstract][Full Text] [Related]
14. FANCD2 as a novel prognostic biomarker correlated with immune and drug therapy in Hepatitis B-related hepatocellular carcinoma. Tang X; Luo B; Huang S; Jiang J; Chen Y; Ren W; Shi X; Zhang W; Shi L; Zhong X; Lü M Eur J Med Res; 2023 Oct; 28(1):419. PubMed ID: 37821996 [TBL] [Abstract][Full Text] [Related]
15. RAC1 serves as a prognostic factor and correlated with immune infiltration in liver hepatocellular carcinoma. Li Y; Gu A; Yang L; Wang Q J Cancer Res Clin Oncol; 2024 Sep; 150(9):418. PubMed ID: 39264423 [TBL] [Abstract][Full Text] [Related]
16. Correlation of MKI67 with prognosis, immune infiltration, and T cell exhaustion in hepatocellular carcinoma. Wu SY; Liao P; Yan LY; Zhao QY; Xie ZY; Dong J; Sun HT BMC Gastroenterol; 2021 Nov; 21(1):416. PubMed ID: 34724892 [TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of MICALL1 and associates with immune infiltration in liver hepatocellular carcinoma patients. Yang Y; Zhao W; Du J; Wang Y Cancer Biomark; 2023; 37(3):147-160. PubMed ID: 37248888 [TBL] [Abstract][Full Text] [Related]
18. Fanconi Anemia Complementary Group A (FANCA) Facilitates the Occurrence and Progression of Liver Hepatocellular Carcinoma. Huang FD; Zhong YP; Sun GY; Xu QJ; Xing ZY; Chen KH; Liao LS; Dong MY Dig Dis Sci; 2024 Mar; 69(3):1035-1054. PubMed ID: 38282187 [TBL] [Abstract][Full Text] [Related]
19. Correlation analysis of RDM1 gene with immune infiltration and clinical prognosis of hepatocellular carcinoma. Qiu C; Li Z; Cao W; Cai X; Ye L; Zhang C; Ma Y; Wang X; Yang Y Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34435618 [TBL] [Abstract][Full Text] [Related]
20. Protein Regulator of Cytokinesis 1 (PRC1) Upregulation Promotes Immune Suppression in Liver Hepatocellular Carcinoma. Zhang C; Xu H; Sui X; Wu T; Chen B; Wang S; Wang X J Immunol Res; 2022; 2022():7073472. PubMed ID: 35983074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]